LOGLIO, ALESSANDRO

LOGLIO, ALESSANDRO  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 20 di 21 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide 1-gen-2020 Loglio A.Soffredini R.Facchetti F.di Paolo D.Lampertico P. + Article (author) -
Circulating cell-free DNA species affect the risk of hepatocellular carcinoma in treated chronic hepatitis B patients 1-mar-2021 Loglio A.Facchetti F.Lampertico P. + Article (author) -
Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long-term analogue therapy for hepatitis B 1-ago-2018 A. LoglioM. IavaroneM. ViganòM. G. RumiF. FacchettiP. Lampertico + Article (author) -
The combination of PIVKA-II and AFP improves the detection accuracy for HCC in HBV caucasian cirrhotics on long-term oral therapy 1-gen-2020 Loglio A.Facchetti F.Di Paolo D.Perbellini R.Lampertico P. + Article (author) -
Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir 1-gen-2019 Loglio A.Facchetti F.Rumi M.Lampertico P. + Article (author) -
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population 1-giu-2018 A. LoglioP. Lampertico + Article (author) -
Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis : a case report of 3 patients 1-ott-2019 Loglio A.Perbellini R.Giovanelli S.Lampertico P. + Article (author) -
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies : two case reports 1-ott-2017 M. ViganòF. FacchettiA. LoglioP. CorradiniP. Lampertico + Article (author) -
Hepatitis B virus long-term impact of antiviral therapy nucleot(s)ide analogues (NUCs) 1-gen-2017 M. ViganòA. LoglioP. Lampertico + Article (author) -
Hepatitis D–how is the fight against this foe going? 1-gen-2019 Loglio, AlessandroSegato, SimoneLampertico, Pietro Article (author) -
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B 1-giu-2020 Loglio A.Lampertico P. + Article (author) -
How Durable Is Functional Cure (Hepatitis B Surface Antigen Loss) in Patients With Chronic Hepatitis B Treated With Current Antivirals? 1-gen-2020 Loglio, AlessandroLampertico, Pietro Article (author) -
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients 1-mar-2018 E. GalmozziF. FacchettiA. LoglioM. Vigano'M.G. ColomboP. Lampertico + Article (author) -
Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma 7-set-2018 Loglio, AlessandroViganò, MauroFarina, LuciaRumi, MariagraziaCorradini, PaoloFacchetti, FlorianaBaldini, LucaLampertico, Pietro + Article (author) -
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices : a 12-year prospective cohort study 1-gen-2015 P. LamperticoF. InvernizziM. Vigano'A. LoglioG. MangiaF. FacchettiM. JovaniM.A. IavaroneG. CasazzaR. DE FRANCHISM.G. Colombo + Article (author) -
Minimal increases of serum alpha-foetoprotein herald HCC detection in Caucasian HBV cirrhotic patients under long-term oral therapy 1-ott-2019 Loglio A.Orenti A.Facchetti F.Cortinovis I.Rumi M.Lampertico P. + Article (author) -
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B 1-nov-2017 A. LoglioM.G. ColomboP. Lampertico + Article (author) -
Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients 1-apr-2019 Testoni, BarbaraLoglio, AlessandroFacchetti, FlorianaLampertico, Pietro + Article (author) -
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B 1-nov-2020 Loglio A.Lampertico P. + Article (author) -
Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance 1-gen-2018 A. LoglioF. FacchettiR.M. SoffrediniE. GalmozziP. Lampertico + Article (author) -